BIOPORTO A/S

BIOPOR.CO — scored out of ten from its own filings

Figures as at 2025-12-31, reported in DKK. The newest fact in the filings is dated 2026-01-01, 235 days ago. Nothing on this page is advice.

The five scores

Dimension	What it asks	Score
Quality	How much of the revenue is really kept — and what did it take to earn it?	2.4
Valuation	What does the price ask for what the company earns, owns and pays out?	0.5
Durability	How predictable is the revenue, and how much of it is already committed?	0.5
Resilience	Can the balance sheet absorb a bad year?	6.5
Growth	Is the business getting bigger, and is it getting more profitable?	2.62

A dimension reading not measured means the filing does not carry the figures it needs. It is left out of the total rather than scored as though it were bad.

What each measure said

A dimension's score is the weighted average of these. Each links to the page explaining how it is worked out and which XBRL tags it reads.

Quality — 2.4

Measure	What it is	Score
SBC / sales	Stock compensation over revenue, inverted	10.0
Oper. margin	GAAP operating margin	0.5
ROIC	Return on invested capital	0.5
OE margin	(Free cash flow − stock comp) over revenue	0.5
Adj. EBITDA margin	Cash operating margin, before stock compensation	0.5

Resilience — 6.5

Measure	What it is	Score
Current ratio	Current ratio, excluding deferred revenue from the liabilities	10.0
ND/EBITDA	Net cash, or net debt over EBITDA	9.0
Interest cover, EBIT over interest	Interest cover, EBIT over interest	0.5

Growth — 2.62

Measure	What it is	Score
Sales/sh Y/Y	Revenue growth per diluted share, trailing twelve months against the prior twelve	2.62

A measure missing from a list here could not be computed from this company's filings. It is left out rather than scored as though it were bad.

The ratios

The figures themselves rather than their scores — what somebody looking up BIOPOR.CO on one particular measure came for.

Ratio	Value
cash operating margin	-215.28
current ratio	3.25
current ratio reported	3.25
fcf margin	-191.29
interest cover	-41.92
operating margin	-213.7
owner earnings margin	-189.71
revenue growth	11.16
revenue growth per share	11.16
roic	-838.03
rule of 40	-202.54
sbc pct revenue	-1.58

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

Figure	Value	XBRL tag	As at
capex	0	`PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities`	2025-12-31
cash	54,893,000	`CashAndCashEquivalents`	2026-01-01
current assets	84,958,000	`CurrentAssets`	2026-01-01
current liabilities	26,124,000	`CurrentLiabilities`	2026-01-01
equity	63,009,000	`Equity`	2026-01-01
interest expense	2,054,000	`FinanceCosts`	2025-12-31
ocf	-77,066,000	`CashFlowsFromUsedInOperatingActivities`	2025-12-31
revenue	40,287,000	`Revenue`	2025-12-31
sbc	-637,000	`AdjustmentsForSharebasedPayments`	2025-12-31

What to be careful about

revenue is annual, not TTM
operating income is annual, not TTM
no market cap; set `market_cap` in overrides.yaml
no usable diluted share count, so growth is measured on total revenue rather than per share; a company issuing shares to fund that growth reads better than it is
no forward EPS estimate; growth rests on filings only. Analyst consensus is not published in XBRL, so it has to be fetched from a data provider or set by hand in overrides.yaml as `eps_growth_2y`
valuation DROPPED from the total: only 0 of 2 inputs could be computed (ev sales, ev owner earnings not tagged), so the score is not meaningful. Its weight is spread over the other dimensions

See it scored yourself

The dashboard puts BIOPOR.CO beside other companies and lets you change what counts: the weight of each dimension, the value that earns a ten, and which of the 61 measures are included at all.